Investor Relations

A leadership story in the field of advanced cell therapy

Day High:
Day Low:
Volume:
on
Copyright West LLC. Minimum 15 minutes delayed.

Investor Relations

Press Releases

September 8, 2021

Vericel to Participate in the Morgan Stanley 19th Annual Global Healthcare Conference on September 13th, 2021

September 7, 2021

Vericel Expands Executive Leadership Team and Announces Appointment of Patrick Fowler as Senior Vice President, Corporate Development and Strategy

August 4, 2021

Vericel Reports Second Quarter 2021 Financial Results and Raises Full-Year 2021 Revenue Guidance

Quarterly Results

Show all

Stock Quote & Analyst Coverage

Stock Quote ()

Change
Volume
Today's Open
Previous Close
Today's High
Today's Low
52 Week High
52 Week Low
Vericel Corporation is covered by the following analysts.
Ryan Zimmerman
BTIG
Swayampakula Ramakanth
H.C. Wainwright & Co.
Jeff Cohen
Ladenburg Thalmann
Danielle Antalffy
LEERINK
Kevin DeGeeter
Oppenheimer
Chris Cooley
Stephens
Samuel Brodovsky
Truist

Vericel Corporation is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Vericel Corporation's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Vericel Corporation or its management. Vericel Corporation does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.